MetaShape

metashapepharma logo

Cracking the metabolic code for millions at risk

MetaShape Pharma is pioneering a first-in-class
oral therapy that restores metabolic balance for
remarkable health benefits.

THE PROBLEM

The true cost of obesity lies beneath

Millions live with hidden metabolic dysfunction, increasing their risk of heart disease, diabetes, and organ damage. Yet today’s treatments typically focus on symptoms, not root causes.

While GLP-1 agonists and other therapies have transformed care for many patients, still many are left behind—whether due to intolerability, side effects, or the complexity of injectable therapies. MetaShape Pharma is pioneering a different approach to metabolic health.

OUR SOLUTION

A smarter solution for metabolic health

MS001, metaShape’s multipotent oral therapy, restores the body’s ability to process glucose, cholesterol, and fat—resetting metabolic health from the inside out.

Targets the root causes – A long-term therapy to restore metabolic health and prevent chronic diseases.

Simple, once-daily oral therapy – No needles, no complex regimens.

Built on proven science – A validated mechanism proven to be safe in over 500 patients.

HOW IT WORKS

PNP inhibitor, MS001

MS 001 is a potent, selective inhibitor of purine nucleoside phosphorylase (PNP) that combines the safety of a drug established from Phase I and II studies with the ground-breaking potential of a new, patented chemical entity with a novel method of use.

Resets metabolism
Helps the body efficiently process glucose and fat.

Boosts cellular energy
Elevates nicotinamide adenine dinucleotide (NAD+) and enhances mitochondrial function.

Reduces chronic inflammation
Lowers uric acid, a hidden driver of chronic disease.

WHY NOW

A breakthrough approach is urgently needed.

of patients stop GLP-1 agonists within a year due to side effects and cost.

of borderline overweight or lean patients with metabolic disease lack treatment options.

the staggering global burden of metabolic disease, and it’s still growing.

WHO WE ARE

About metaShape

At metaShape, we believe in tackling metabolic disease at its source.

Led by a team of biotech leaders with decades of expertise in internal medicine, drug development and PNP biology, we are committed to unlocking accessible, long-term solutions for millions.

NAD+ Metashapepharma

Our Latest News

3 Sep, 2023

  By Kevin Martin    2 Comments

Lorem ipsum dolor sit amet, adipiscing elit.

3 Sep, 2023

  By Kevin Martin   5  Comments

Lorem ipsum dolor sit amet, adipiscing elit.

3 Sep, 2023

  By Kevin Martin    1 Comments

Lorem ipsum dolor sit amet, adipiscing elit.

CONTACT US

Join us in shaping the future of metabolic health

Whether you're a researcher, investor, or healthcare provider, the time to redefine metabolic care is now.

For general enquiries, please contact:

info@metashapepharma.com

For investor-related enquiries, please contact:

mehrling@metashapepharma.com

CONTACT FORM